Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe Record History gained new entries for Contacts/Locations and Study Status, with revision v3.5.0 released on 2026-03-18. The 2025-11-21 entry and revision v3.4.3 were removed.SummaryDifference0.6%

- Check26 days agoChange DetectedA new revision entry, v3.4.3, was added. The previous revision, v3.4.2, was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and the government funding lapse notice along with the prior revision entry (v3.4.1) were removed from the visible history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check61 days agoChange DetectedThe page history shows a new system notice about government funding and a new revision tag (v3.4.1) replacing the previous revision (v3.4.0).SummaryDifference0.8%

- Check68 days agoChange DetectedThe page now shows a glossary option and uses color-coded highlights for changes, with a new revision note for v3.4.0; the No FEAR Act data entry was removed and the older v3.3.4 revision is no longer shown.SummaryDifference1.0%

- Check82 days agoChange DetectedAdded a new revision entry: v3.3.4, and removed the previous revision entry: v3.3.3 from the Record History version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.